Dale Muzzey - Apr 14, 2022 Form 4 Insider Report for MYRIAD GENETICS INC (MYGN)

Role
Chief Scientific Officer
Signature
By: Nathan A. Smith For: Dale Muzzey
Stock symbol
MYGN
Transactions as of
Apr 14, 2022
Transactions value $
$0
Form type
4
Date filed
4/14/2022, 05:07 PM
Next filing
Sep 27, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MYGN Common Stock Award $0 +7.5K +20.66% $0.00 43.8K Apr 14, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in four equal annual installments beginning on the first anniversary of the grant date.